Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Heng

Showing results (101-110 of 306) with videos related to

Pageof 31
Sort By:
JCO Clinical Cancer Informatics|August 31, 2021
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney CancerKevin Shee, Sumanta K Pal, J Connor Wells, et al.
Clinical Genitourinary Cancer|December 2, 2020
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United StatesMatteo Santoni, Francesco Piva, Camillo Porta, et al.
Nanotechnology|June 26, 2018
Blister-based-laser-induced-forward-transfer: a non-contact, dry laser-based transfer method for nanomaterialsN T Goodfriend, S Y Heng, O A Nerushev, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapyAli Reza Golshayan, Saby George, Daniel Y Heng, et al.
The Journal of Clinical Investigation|May 17, 2013
Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse modelMary Y Heng, Shu-Ting Lin, Laure Verret, et al.
Genes, Brain, and Behavior|July 21, 2007
Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoterB C McKinney, J S Schneider, G L Schafer, et al.
Urology|March 13, 2010
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapyMichael M Vickers, Toni K Choueiri, Miranda Rogers, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 11, 2013
Estimation of birth population-based perinatal-neonatal mortality and preterm rate in China from a regional survey in 2010L Sun, H Yue, B Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyD Y Heng, M J Mackenzie, U N Vaishampayan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2015
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancerD M Jiang, S Raissouni, J Mercer, et al.
Pageof 31

Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
JCO Clinical Cancer Informatics|August 31, 2021
Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney CancerKevin Shee, Sumanta K Pal, J Connor Wells, et al.
Clinical Genitourinary Cancer|December 2, 2020
Artificial Neural Networks as a Way to Predict Future Kidney Cancer Incidence in the United StatesMatteo Santoni, Francesco Piva, Camillo Porta, et al.
Nanotechnology|June 26, 2018
Blister-based-laser-induced-forward-transfer: a non-contact, dry laser-based transfer method for nanomaterialsN T Goodfriend, S Y Heng, O A Nerushev, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapyAli Reza Golshayan, Saby George, Daniel Y Heng, et al.
The Journal of Clinical Investigation|May 17, 2013
Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse modelMary Y Heng, Shu-Ting Lin, Laure Verret, et al.
Genes, Brain, and Behavior|July 21, 2007
Decreased locomotor activity in mice expressing tTA under control of the CaMKII alpha promoterB C McKinney, J S Schneider, G L Schafer, et al.
Urology|March 13, 2010
Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapyMichael M Vickers, Toni K Choueiri, Miranda Rogers, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|April 11, 2013
Estimation of birth population-based perinatal-neonatal mortality and preterm rate in China from a regional survey in 2010L Sun, H Yue, B Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2011
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyD Y Heng, M J Mackenzie, U N Vaishampayan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2015
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancerD M Jiang, S Raissouni, J Mercer, et al.
Pageof 31